Sunday, January 11, 2026

January 11, 2026 at 08:58PM Cellular & Gene Therapy Products

CBER provides oversight of clinical studies, proactive scientific and regulatory advice to medical researchers and manufacturers of cellular therapy products, human gene therapy products, and certain devices related to cell and gene therapy.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zGMAjtd

No comments:

Post a Comment